858671-74-6 Usage
Uses
Used in Pharmaceutical Industry:
Ethyl 6-bromobenzo[d]isothiazole-3-carboxylate is used as a key intermediate in the synthesis of various pharmaceuticals for its antimicrobial and antifungal properties. It aids in the development of new drugs and treatments targeting a wide range of infections and diseases.
Used in Chemical Research:
In the field of chemical research, Ethyl 6-bromobenzo[d]isothiazole-3-carboxylate is used as a subject of study to explore its potential applications in medicine and healthcare. Researchers investigate its chemical properties, interactions with other compounds, and possible uses in drug development.
Used in Laboratory Experiments:
Ethyl 6-bromobenzo[d]isothiazole-3-carboxylate is utilized in laboratory experiments to test its efficacy and safety in various applications. These experiments help to determine the optimal conditions for its use in pharmaceutical formulations and to identify any potential side effects or limitations.
Overall, Ethyl 6-bromobenzo[d]isothiazole-3-carboxylate is a promising compound with diverse potential uses in the pharmaceutical and medical industries, offering a valuable contribution to the development of new treatments and therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 858671-74-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,8,6,7 and 1 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 858671-74:
(8*8)+(7*5)+(6*8)+(5*6)+(4*7)+(3*1)+(2*7)+(1*4)=226
226 % 10 = 6
So 858671-74-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H8BrNO2S/c1-2-14-10(13)9-7-4-3-6(11)5-8(7)15-12-9/h3-5H,2H2,1H3
858671-74-6Relevant articles and documents
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
-
Page/Page column 62, (2010/11/26)
The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nACh receptors), activation of nACh receptors, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds (e.g., indazoles and benzothiazoles), which act as ligands for the α7 nACh receptor subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
1 H-INDAZOLES, BENZOTHIAZOLES, 1,2-BENZOISOXAZOLES, 1,2-BENZOISOTHIAZOLES, AND CHROMONES AND PREPARATION AND USES THEREOF
-
Page/Page column 69, (2010/11/27)
The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nAChR), activation of nAChRs, and the treatment of -disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds (indazoles and benzothiazoles), which act as ligands for the α7 nAChR subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
